VentriPoint Diagnostics (TSE:VPT) has released an update.
Ventripoint Diagnostics Ltd. is extending its non-brokered private placement of unsecured convertible debentures, aiming to close the balance of the offering by June 25, 2024. Investors have the option to convert each $1,000 debenture into 4,000 common shares at $0.25 per share, with an interest rate of 10% per annum. The proceeds from this offering will be utilized for the company’s operational expenses, sales and marketing efforts, hiring additional key personnel, and general working capital.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
